AAAAAA
Results: 1-25/37
Authors:
HAVAS HF
AXELROD RS
BURNS MM
MURASKO D
GOONEWARDENE M
Citation: Hf. Havas et al., CLINICAL-RESULTS AND IMMUNOLOGICAL EFFECTS OF A MIXED BACTERIAL VACCINE IN CANCER-PATIENTS, Medical oncology and tumor pharmacotherapy, 10(4), 1993, pp. 145-158
Authors:
HATSCHEK T
BALDETORP L
CARSTENSEN J
HAKANSSON L
MOLLER T
NILSSON B
TERMANDER B
Citation: T. Hatschek et al., CONTINUOUS VERSUS INTERMITTENT PREDNIMUSTINE TREATMENT OF NON-HODGKINS-LYMPHOMA, Medical oncology and tumor pharmacotherapy, 10(4), 1993, pp. 159-166
Authors:
AXELSON O
FORASTIERE F
Citation: O. Axelson et F. Forastiere, RADON AS A RISK FACTOR FOR EXTRA-PULMONARY TUMORS, Medical oncology and tumor pharmacotherapy, 10(4), 1993, pp. 167-172
Authors:
CSANAKY G
VASS JA
LOSONCZY H
SCHMELCZER M
Citation: G. Csanaky et al., EXPRESSION OF AN ADHESION MOLECULE AND HOMING IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA .2. L-SELECTIN EXPRESSION MEDIATED CELL-ADHESION REVEALED BY IMMOBILIZED ANALOG CARBOHYDRATES IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA AND MONOCLONAL LYMPHOCYTOSIS OF UNDETERMINED SIGNIFICANCE, Medical oncology and tumor pharmacotherapy, 10(4), 1993, pp. 173-180
Authors:
FOLLEZOU JY
CHAUVEINC L
GUERIN JM
Citation: Jy. Follezou et al., CEREBRAL ARTERIAL DISTURBANCES IN A TRANSIENT ENCEPHALOPATHY INDUCED BY METHOTREXATE, Medical oncology and tumor pharmacotherapy, 10(4), 1993, pp. 181-183
Authors:
BATAILLE R
ZHANG XG
WIJDENES J
SCHVED JF
KLEIN B
Citation: R. Bataille et al., EFFECTS OF AN ANTI-INTERLEUKIN-6 (IL-6) MURINE MONOCLONAL-ANTIBODY INA PATIENT WITH ACUTE MONOBLASTIC LEUKEMIA, Medical oncology and tumor pharmacotherapy, 10(4), 1993, pp. 185-188
Authors:
BJORNHAGEN V
MANSSONBRAHME E
LINDHOLM J
MATTSSON A
AUER G
Citation: V. Bjornhagen et al., MORPHOMETRIC, DNA AND PCNA IN THIN MALIGNANT MELANOMAS, Medical oncology and tumor pharmacotherapy, 10(3), 1993, pp. 87-94
Authors:
MCADAM B
SMITH T
LOVE WC
MURPHY M
DALY PA
Citation: B. Mcadam et al., LACTATE-DEHYDROGENASE LEVELS DURING MACOP-B CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA, Medical oncology and tumor pharmacotherapy, 10(3), 1993, pp. 95-101
Authors:
WERSALL JP
MASUCCI G
HJELM AL
RAGNHAMMAR P
FAGERBERG J
FRODIN JE
MERK K
LINDEMALM C
ERICSON K
KALIN B
MELLSTEDT H
Citation: Jp. Wersall et al., LOW-DOSE CYCLOPHOSPHAMIDE, ALPHA-INTERFERON AND CONTINUOUS INFUSIONS OF INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA, Medical oncology and tumor pharmacotherapy, 10(3), 1993, pp. 103-111
Authors:
CAVDAR AO
BABACAN E
GOZDASOGLU S
YAVUZ G
UNAL E
PAMIR A
Citation: Ao. Cavdar et al., T-LYMPHOCYTE SUBPOPULATIONS IN ORBITOOCULAR GRANULOCYTIC SARCOMA (OOGS) AND ACUTE MYELOCYTIC-LEUKEMIA (AML) - A PRELIMINARY-STUDY, Medical oncology and tumor pharmacotherapy, 10(3), 1993, pp. 113-115
Authors:
OHWADA Y
EGUCHI M
Citation: Y. Ohwada et M. Eguchi, ULTRASTRUCTURAL INVESTIGATION OF DNA IN MEGAKARYOBLASTIC LEUKEMIA BY USING OSMIUM-AMMINE-B - COMPARISON WITH SEVERAL TYPES OF LEUKEMIA, Medical oncology and tumor pharmacotherapy, 10(3), 1993, pp. 117-124
Authors:
CSANAKY G
KALASZ V
KELENYI G
LOSONCZY H
BALIKO Z
TOTH A
Citation: G. Csanaky et al., EXPRESSION OF AN ADHESION MOLECULE AND HOMING IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA .1. APPLICATION OF THE HEV-BINDING ASSAY TO A CLINICAL-SERIES, Medical oncology and tumor pharmacotherapy, 10(3), 1993, pp. 125-129
Authors:
HOEKSTRA A
BASSOT V
BERTOGLIO S
BOBIN JY
DELASSUS P
EGELI R
KHAYAT D
RANCHERE JY
SANTINI J
SEGOL P
Citation: A. Hoekstra et al., CLINICAL-EVALUATION OF THE CORDIS VASCULAR ACCESS PORT SYSTEMS - A MULTICENTER STUDY, Medical oncology and tumor pharmacotherapy, 10(3), 1993, pp. 131-138
Authors:
EINHORN N
Citation: N. Einhorn, TREATMENT OF OVARIAN-CANCER - THE STATE-OF-THE-ART, Medical oncology and tumor pharmacotherapy, 10(3), 1993, pp. 139-142
Authors:
REIZENSTEIN P
STENKE L
Citation: P. Reizenstein et L. Stenke, REGULATION OF GRANULOCYTOSIS IN INFLAMMATORY DISEASE AND IN LEUKEMIA, Medical oncology and tumor pharmacotherapy, 10(1-2), 1993, pp. 1-3
Authors:
HANSSON M
SODERSTROM T
Citation: M. Hansson et T. Soderstrom, THE COLONY-STIMULATING FACTORS, Medical oncology and tumor pharmacotherapy, 10(1-2), 1993, pp. 5-12
Authors:
LOTZOVA E
SAVARY CA
Citation: E. Lotzova et Ca. Savary, INDUCTION OF CYTOTOXIC LYMPHOCYTE SUBSETS AGAINST LEUKEMIA BY STIMULATION WITH AML BLASTS, Medical oncology and tumor pharmacotherapy, 10(1-2), 1993, pp. 13-19
Authors:
JANSON CH
Citation: Ch. Janson, BIOLOGY OF MONOCLONAL-ANTIBODIES IN TUMOR-THERAPY, Medical oncology and tumor pharmacotherapy, 10(1-2), 1993, pp. 21-23
Authors:
EINHORN S
STRANDER H
Citation: S. Einhorn et H. Strander, INTERFERON TREATMENT OF HUMAN MALIGNANCIES - A SHORT REVIEW, Medical oncology and tumor pharmacotherapy, 10(1-2), 1993, pp. 25-29
Authors:
FRIBERG S
Citation: S. Friberg, BCG IN THE TREATMENT OF SUPERFICIAL CANCER OF THE BLADDER - A REVIEW, Medical oncology and tumor pharmacotherapy, 10(1-2), 1993, pp. 31-36
Authors:
KALLAND T
DOHLSTEN M
LIND P
SUNDSTEDT A
ABRAHMSEN L
HEDLUND G
BJORK P
LANDO PA
BJORKLUND M
Citation: T. Kalland et al., MONOCLONAL-ANTIBODIES AND SUPERANTIGENS - A NOVEL THERAPEUTIC APPROACH, Medical oncology and tumor pharmacotherapy, 10(1-2), 1993, pp. 37-47
Authors:
STEINITZ M
LIVOFF A
TAMIR S
BRENNER T
Citation: M. Steinitz et al., SEPARATION OF RARE CELL SUBPOPULATIONS WITH THE AID OF BIOTIN-LABELEDLIGANDS, Medical oncology and tumor pharmacotherapy, 10(1-2), 1993, pp. 49-52
Authors:
DIPIERRO F
CAVALLO F
PERICLE F
BERTINI S
GIOVARELLI M
FORNI G
Citation: F. Dipierro et al., STRATEGIES FOR CYTOKINE UTILIZATION IN TUMOR-THERAPY, Medical oncology and tumor pharmacotherapy, 10(1-2), 1993, pp. 53-59
Authors:
RAGNHAMMAR P
MAGNUSSON I
MASUCCI G
MELLSTEDT H
Citation: P. Ragnhammar et al., THE THERAPEUTIC USE OF THE UNCONJUGATED MONOCLONAL-ANTIBODIES (MAB) 17-1A IN COMBINATION WITH GM-CSF IN THE TREATMENT OF COLORECTAL-CARCINOMA (CRC), Medical oncology and tumor pharmacotherapy, 10(1-2), 1993, pp. 61-70
Authors:
WERSALL P
Citation: P. Wersall, INTERLEUKIN-2 AND INTERFERON IN RENAL-CELL CARCINOMA, Medical oncology and tumor pharmacotherapy, 10(1-2), 1993, pp. 71-76